Related Experiment Video
Updated: Aug 9, 2026

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Novel effects of azithromycin on tight junction proteins in human airway epithelia
Valthor Asgrimsson1, Thorarinn Gudjonsson, Gudmundur Hrafn Gudmundsson
1Faculty of Medicine, Landspitali University Hospital, Fossvogi E7, 108 Reykjavik, Iceland.
Abstract:
The macrolide antibiotic azithromycin improves lung function and prognosis among patients with cystic fibrosis or diffuse panbronchiolitis, independently of bacterial eradication. Anti-inflammatory effects have been implicated, but data from in vivo studies are scarce, and the link between abnormal electrolyte content in airway surface liquid and bronchial infections remains uncertain. In the present study, we treated human airway epithelia on filter supports with azithromycin and monitored transepithelial electrical resistance. We found that azithromycin increased transepithelial electrical resistance of airway epithelia in a dose-dependent manner. Immunocytochemistry and Western blotting showed that addition of azithromycin changed the locations of proteins in cell cultures and induced processing of the tight junction proteins claudin-1 and claudin-4, occludin, and junctional adhesion molecule-A. These effects were reversible, and no effect was seen when cells were treated with penicillin or erythromycin. The data indicate that azithromycin increases the transepithelial electrical resistance of human airway epithelia by changing the processing of tight junction proteins. The results are novel and may help explain the beneficial effects of azithromycin in patients with cystic fibrosis, diffuse panbronchiolitis, and community-acquired pneumonia.
Insights
Azithromycin enhances airway epithelial barrier function by altering tight junction proteins, independent of its antibiotic action. This may explain its benefits in chronic lung diseases like cystic fibrosis.
Area of Science:
- Pulmonology
- Cell Biology
- Pharmacology
Background:
- Macrolide antibiotics like azithromycin improve outcomes in cystic fibrosis and diffuse panbronchiolitis.
- Anti-inflammatory effects are proposed, but in vivo data are limited.
- The role of airway surface liquid electrolyte balance in bronchial infections is unclear.
Purpose of the Study:
- To investigate the in vitro effects of azithromycin on human airway epithelial barrier function.
- To elucidate the molecular mechanisms underlying azithromycin's impact on airway epithelia.
Main Methods:
- Human airway epithelial cells cultured on filter supports were treated with azithromycin.
- Transepithelial electrical resistance (TEER) was measured.
- Immunocytochemistry and Western blotting analyzed tight junction protein expression and localization.
Main Results:
- Azithromycin dose-dependently increased TEER in airway epithelia.
- Azithromycin altered the localization and processing of tight junction proteins, including claudin-1, claudin-4, occludin, and JAM-A.
- These effects were reversible and specific to azithromycin, not observed with penicillin or erythromycin.
Conclusions:
- Azithromycin enhances human airway epithelial barrier integrity by modulating tight junction protein processing.
- This mechanism offers a potential explanation for azithromycin's therapeutic benefits in chronic airway diseases.
- Findings contribute to understanding azithromycin's non-antibiotic effects in conditions like cystic fibrosis and pneumonia.
Related Concept Videos
Tight Junctions
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
